Regulations.gov document
Tab 3 - "HCV Treatment With Pegylated Interferon and Ribavirin in Patients With…
Supporting & Related Material · FDA-2009-P-0471 · posted Oct 5, 2009
Key facts
| Document ID | FDA-2009-P-0471-0003 |
|---|---|
| Title | Tab 3 - "HCV Treatment With Pegylated Interferon and Ribavirin in Patients With Haemophilia and HIV/HCV Co-Infection" - [Mark Antell, et al - Citizen Petition ] re FDA-2009-P-0471-0001 |
| Document type | Supporting & Related Material |
| Subtype | BKG-Background Material |
| Agency | FDA |
| Docket | FDA-2009-P-0471 |
| Posted | Oct 5, 2009 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: